Throughout the pandemic, testing has continued to be one of the biggest issues, particularly in the United States. Some scientists say that the solution is to rethink our COVID-19 testing strategy, focusing on making faster, cheaper tests. While these more cost-effective tests may be lower in sensitivity than the PCR tests and perhaps not as accurate, they would allow for more people to get tested and receive faster results. The system can also help improve case tracking—which is essential as more people return to work, school, and daily lives. Eric Topol, the founder and director of the Scripps Research Translational Institute, talks about how these tests can look ahead for infectious patients rather than those already infected. Plus, epidemiologist Anne Wyllie walks us through what the process would look like to develop a rapid test.
- Michael Lewis on the Mirage That Is America’s Public Health System June 4, 2021
- NIH Director’s Wednesday Afternoon Lecture Series May 19, 2021
- “We Are So Damn Fortunate” — The End of COVID Could Come If You and I Convinced Everyone We Know To Get Their Shot May 14, 2021
- Imagine the Worst, or We’re at Our Own Peril: Osterholm May 14, 2021